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ABSTRACT
Polyadenylation is a co-transcriptional process that
modifies mRNA 30-ends in eukaryotes. In yeast,
CF IA and CPF constitute the core 30-end maturation
complex. CF IA comprises Rna14p, Rna15p, Pcf11p
and Clp1p. CF IA interacts with the C-terminal
domain of RNA Pol II largest subunit via Pcf11p
which links pre-mRNA 30-end processing to tran-
scription termination. Here, we analysed the role of
Clp1p in 30 processing. Clp1p binds ATP and inter-
acts in CF IA with Pcf11p only. Depletion of Clp1p
abolishes transcription termination. Moreover, we
found that association of mutations in the ATP-
binding domain and in the distant Pcf11p-binding
region impair 30-end processing. Strikingly, these
mutations prevent not only Clp1p-Pcf11p interaction
but also association of Pcf11p with Rna14p-Rna15p.
ChIP experiments showed that Rna15p cross-
linking to the 30-end of a protein-coding gene is per-
turbed by these mutations whereas Pcf11p is only
partially affected. Our study reveals an essential role
of Clp1p in CF IA organization. We postulate that
Clp1p transmits conformational changes to RNA
Pol II through Pcf11p to couple transcription termin-
ation and 30-end processing. These rearrangements
likely rely on the correct orientation of ATP within
Clp1p.
INTRODUCTION
Polyadenylation is a co-transcriptional event that occurs at
the 30-end of nearly all eukaryotic mRNA precursors (1,2).
This essential maturation process starts with cleavage of
the elongating pre-mRNA in the 30-untranslated region
(30-UTR) followed by the addition of a poly(A) tract at
the 30-hydroxyl end of the upstream cleavage product.
The endonucleolytic cleavage also generates a 50-phos-
phorylated RNA downstream of the poly(A) site that
provides an entry site for the exonuclease Rat1
(in yeast)/Xrn2(in human) which subsequently degrades
this RNA. This exonucleolytic degradation is part of a
complex mechanism that triggers termination of tran-
scription in eukaryotes (3–5). Pre-mRNA processing and
subsequent termination of transcription rely on the rec-
ognition of polyadenylation-speciﬁc sequences on the pri-
mary transcript by the polyadenylation machinery. The
30-end processing complex is now well described in both
yeast and mammals (6–8). In Saccharomyces cerevisiae,
the ﬁrst factor that was identiﬁed at the level of its
subunit composition was the cleavage/polyadenylation
factor IA (CF IA), involved in both the cleavage and
polyadenylation steps (9,10). The polyadenylation com-
plex also comprises the large cleavage and polyadenyla-
tion factor [CPF, with up to 15 different subunits
identiﬁed; (11–13)], the RNA-binding protein Hrp1p/
Nab4p (14,15) and the poly(A)-binding proteins Pab1p
and Nab2p, involved in the control of poly(A) tail syn-
thesis and subsequent export of the mature mRNA
(10,16–18). Multiple protein–protein interactions have
been identiﬁed between subunits of the factors (6,7).
CF IA consists of Rna14p, Rna15p, Pcf11p and Clp1p.
Rna14p and Rna15p interact tightly with each other (19)
and with Pcf11p (20,21). Rna15p is an RNA-binding
protein that cooperates with Hrp1p/Nab4p to speciﬁcally
bind the positioning and efﬁciency elements located up-
stream of the cleavage site (22). Pcf11p is required for both
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ation. Its N-terminus interacts speciﬁcally with the
carboxyl-terminal domain (CTD) of the largest subunit
of RNA polymerase II (Pol II), while the central and
C-terminal regions of Pcf11p contact Rna14p/Rna15p
and Clp1p, respectively (23). The CTD-interacting
domain (CID) of Pcf11p is dispensable for 30-end process-
ing in vitro but is essential to avoid transcriptional
readthrough in vivo (23,24).
It has been reported that Clp1p, upon in vitro reconsti-
tution of the factor with recombinant proteins, associates
with CF IA via Pcf11p, making no contacts with either
Rna14p or Rna15p (21). Although all four subunits
appeared to be required as a complex to fulﬁl CF IA es-
sential function in 30 processing (21), no precise role has
been attributed to Clp1p in this maturation process. First
identiﬁed in yeast as the fourth subunit of CF IA (10),
Clp1 orthologue was subsequently found associated with
hPcf11 in a mammalian factor called Cleavage Factor II
(CF IIm) (25). Interestingly, yeast CF IA is required for
both cleavage and polyadenylation whereas CF IIm acts in
cleavage only. Consistent with the presence of a conserved
P-loop/Walker A motif in its sequence, Clp1p binds ATP
(26). Recently, human Clp1 (hClp1) has been shown to
work in the yeast-like pathway of tRNA splicing and
activate synthetic siRNAs in vitro (27,28). In addition, ex-
pression of hClp1 or its archeal orthologue PhoClp1 (from
Pyrococcus horikoshii) can complement a kinase-defective
mutant of the essential yeast tRNA ligase TRL1 (27–29).
However, hClp1 cannot compensate for the loss of yeast
CLP1 expression (27,28). Despite its structural similarity
with hClp1 (26), yeast Clp1p has no detectable ATPase
activity (26–28). Since the kinase activity for RNA healing
in tRNA splicing is carried out by the multifunctional Trl1
protein (30) and given that no siRNA pathway exists in
budding yeast, it is unlikely that hClp1 and yeast Clp1p
are functional homologues. Therefore, we anticipate that
Clp1p may exert its essential function in pre-mRNA
30-end processing only.
In this study, we investigated the role of Clp1p in
mRNA 30-end formation. Taking advantage of the yeast
system, we looked for conditional lethal mutants that
exhibit temperature-sensitive (Ts) phenotypes at 37 C.
We found that these mutations affect cleavage and poly-
adenylation in vitro. Depletion of Clp1p and Pcf11p in vivo
resulted in transcription termination defects at snoRNA
transcription units. Importantly, the association of
Rna14p/Rna15p to Pcf11p is altered in clp1 Ts mutants.
We propose that the essential function of Clp1p in yeast
is to maintain CF IA organization in order to allow the co-
upling of 30-end processing and transcription termination.
MATERIALS AND METHODS
Wild-type CLP1 plasmid constructs
The open reading frame (ORF) of the CLP1 gene was
ampliﬁed by PCR from BMA64 strain genomic DNA
(Supplementary Table S1; 31) with gene-speciﬁc primers
designed to introduce NotI sites upstream and down-
stream of the start and stop codons. The fragment was
cloned into the NotI site of the yeast shuttle vectors
pHH2 (ARS-CEN, URA3) and pAHH2 (ARS-CEN,
ADE2), allowing the expression of a fusion Clp1 protein
tagged at its N-terminus with the HA epitope-6xHistidine
tag, under the control of the constitutive CYC1 promoter
and PGK1 terminator. A longer fragment around CLP1
ORF was ampliﬁed by PCR from wild-type genomic
DNA starting from position  250 (the A of the start
codon being +1) and ending at position +1650 (312nt
after the stop codon). This fragment was cloned into plas-
mid pFL38 [ARS-CEN, URA3; (32)] and pASZ11
[ARS-CEN, ADE2; (33)]. The constructs (pHH2-CLP1,
pAHH2-CLP1, pFL38-CLP1 and pASZ11-CLP1) were
sequenced to control that no undesired mutation were
introduced by PCR.
Construction of CLP1-deleted strains
Deletion of the entire ORF of the CLP1 gene was done in
the diploid BMA64(2n) strain using a technique already
described (34) with either TRP1 or LEU2 genes as select-
able markers. Correct integration was checked by PCR.
Tetrad analysis after meiosis showed a segregation of 2
Trp
  (or Leu
 ) viable spores and two lethal spores, the
latter corresponding to clp1::TRP1 (or clp1::LEU2) gene
deletion, demonstrating that CLP1 is essential for viabil-
ity. The diploid strains heterozygous for the deletions
were transformed with pHH2-CLP1 or pFL38-CLP1
and sporulated to yield haploid strains YLM127 and
YLM172 (Supplementary Table S1). Most of the strains
used in this study were derived from YLM127 and
YLM172 by plasmid shufﬂing.
Construction of mutant clp1 and pcf11 alleles
Error-prone PCR mutagenesis was performed with plas-
mid pAHH2-CLP1 as template. The PCR reaction was
carried out in the presence of the speciﬁc primers used
to amplify and clone CLP1 ORF in pAHH2-CLP1, and
40mM of dATP, 200mM of each dCTP, dGTP and dTTP
and Taq DNA polymerase. Ampliﬁed fragments were
recloned into pAHH2 empty vector and used to transform
YLM127 strain. Hydroxylamine mutagenesis was per-
formed on pASZ11-CLP1 according to Sikorski and
Boeke (35). Mutagenized plasmids were used to transform
YLM172. All transformants of YLM127 and YLM172
were spread 5-FOA plates to select against the URA3
CLP1-containing plasmids. Viable colonies were tested
then for temperature-sensitivity at 37 C. The original
strains YLM130 (clp1-12 allele) and YLM179 (clp1-5
allele) were obtained through these screens. The other
clp1 alleles used in this study (Figure 1; Supplementary
Table S1) were derived from clp1-12 and clp1-5 by
sub-cloningor site-directedmutagenesisofplasmids,trans-
formed into YLM172 and plated on 5-FOA medium to
chase the plasmid-borne wild-type allele. Serial dilutions
of the resulting transformants were tested on rich medium
for temperature-sensitivity at 37 C. To generate the
R-Clp1p and R-Pcf11p expressing strain (YRH78 and
YRH79, respectively), the GAL promoter and the ubiqui-
tin–arginine coding sequence were fused to their ORFs on
the chromosome as described (36).
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run-on analysis
Cleavage and polyadenylation assays were done as previ-
ously described with either extracts or puriﬁed factors pre-
pared from wild-type and mutant stains with the CYC1
and CYC1 pre-cleaved RNAs. Hrp1p/Nab4p and Nab2p
were recombinant proteins expressed in Escherichia coli
(17,37) Transcription run-on analysis were as described
in Dheur et al. (36). Reverse transcription was performed
on 10mg of total RNA extracted from (i) R-Clp1p and
R-Pcf11p-expressing strains 4h after cells were shifted
from galactose to glucose medium, or (ii) after a 2-h shift
to 37 C for rna15-1 and pti1-2 mutants strains. Products
were analysed on 6% polyacrylamide 8.3% urea gels.
Puriﬁcation of 30-end processing factors and recombinant
proteins
Yeast factors were puriﬁed from the TAP-tagged yeast
strains (Supplementary Table S1) as published (38).
Puriﬁed factors were used for 30 processing assays
in vitro or run on 10% polyacrylamide-SDS gels, stained
with silver or immunoblotted. Recombinant proteins were
produced in E. coli BL21(DE3) cells. PCR products of the
different clp1 alleles were cloned into a pET28-derived
vector and into a modiﬁed pET-15b plasmid, introducing
a His6-tag at the N-terminus of the Pcf11
(454–563) protein.
Bacterial cells were co-transformed with Pcf11p
(454-563)-
and Clp1p-expressing plasmids, grown at 37 C and
further induced overnight with 1mM IPTG at 15 C.
Co-precipitations were performed as described (39).
Chromatin immunoprecipitation
Chromatin immunoprecipitations (ChIPs) were done with
TAP-tagged proteins and quantitative PCR ampliﬁcation
of the immunoprecipitated (IP) fragments were performed
with primers corresponding to the ADH1 gene as de-
scribed (40–42). PCR reactions were run on native
8%-polyacrylamide gels. The gels were ﬁxed, dried,
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Figure 1. Phenotypic analysis of the different clp1 alleles used in this study. (A) Schematic representation of the Ts alleles of the CLP1 gene isolated
after random PCR mutagenesis (clp1-12) or hydroxylamine mutagenesis (clp1-12). The conserved residues constituting the canonical P-loop/Walker A
domain and the Switch loops of Clp1p are depicted on the wild-type protein, between the N-terminal (NtD) and C-terminal (CtD) domains (see also
Supplementary Figure S1). Location of amino acid changes within the Ts alleles are indicated. (B) Ten-fold dilution of the wild-type and original
clp1-12 and clp1-5 mutant strains were spotted on rich medium and incubated for 1 day at 24 C and 37 C. (C) Diagrammatic drawing of the
different alleles derived from the original clp1-5 and clp1-12 mutants. (D) Ten-fold serial dilutions of the wild-type and mutant strains spotted as in
(B) but incubated for 3 days at the indicated temperatures.
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with a Biorad Pharos machine for quantitative measure-
ments of the IP material. Occupancies at each position
were calculated by dividing the ratio of the IP over
the corresponding Input DNA at each location of the
ADH1 gene, by the ratio of IP over Input of a
non-transcribed region of chromosome V, as explained
in (40). For easier comparisons, the value obtained with
fragment number 3 for each immunoprecipitation at 24 C
was set up to 100 and the other values were expressed
proportionally.
RESULTS
clp1 conditional mutants deﬁne two important regions in
the Clp1 protein
Although Clp1p is an essential subunit of the yeast pre-
mRNA 30-end processing machinery (10,21), its role re-
mains unknown. In order to gain further insight into its
function, we employed error-prone PCR and chemical
mutagenesis to generate random mutations in the CLP1
gene. The plasmid-borne mutant alleles were introduced
by plasmid-shufﬂing into a strain carrying the clp1D null
allele. The resulting mutant strains were tested for
temperature-sensitivity and two independent mutants
were identiﬁed that were unable to grow at 37 C. The
clp1-12 resulted from random PCR mutagenesis, and the
clp1-5 allele was obtained by hydroxylamine mutagenesis
(Figure 1A and B). Mapping the mutations within the clp1
mutant ORFs revealed six and two point mutations within
the clp1-12 and clp1-5 alleles, respectively (Figure 1A). To
seek out the simplest modiﬁcations that were responsible
for the Ts phenotype, we separated the mutations in the
two alleles. Interestingly, the combination of both muta-
tions (G135R, G335S) was required for the Ts phenotype
of the clp1-5 mutant, as each mutation independently
conferred a temperature-resistant phenotype [Figure 1C,
clp1-1 (G135R) and clp1-6 (G335S); Figure 1D, rows d
and e]. Likewise, simpliﬁcation of the Ts mutant allele
clp1-12 (6 mutations) gave rise to both the Ts clp1-15
mutant (G135R, H267Q, L341S) and the temperature-
resistant clp1-13 allele (H267Q, L341S), (Figure 1C and
D, see rows g and h, respectively). Sequence inspection of
Clp1 orthologues showed that G135 lies within highly
conserved residues constituting the P-loop/Walker A
motif. This motif is found in most ATP-/GTP-binding
proteins and forms the nucleotide binding site within the
central domain [Figure 1A and Supplementary Figure S1;
(43)]. Speciﬁcally, the backbone amide of G135 makes
direct contact with the b-phosphate group of the bound
ATP (26). Given that eight additional residues are in the
vicinity of the nucleotide [6 in the central domain and 2 in
the N-terminal domain; (26)], it is not surprising that the
G135R mutation alone did not abolish Clp1p function
that may be linked to ATP binding. The second-site
mutation in clp1-5, G335S, belongs to a perfectly con-
served sequence region (YFYG) found at the interface with
another CF IA essential subunit, Pcf11p [Supplementary
Figure S1; (26)]. Similar to G135R, this mutation does not
independently result in a Ts phenotype (in the clp1-6
mutant). The L341S mutation, found in the clp1-15 Ts
mutant allele, also lies close to the Pcf11p interaction
surface and is not capable of eliciting a Ts phenotype on
its own (Figure 1C, mutant clp1-19, and Figure 1D, row l).
Interestingly, combination of both G335S and L341S
within the same allele (called clp1-17; Figure 1C) is still
unable to cause a growth defect (Figure 1D, row k). We
observed that a third mutation, H267Q, in the clp1-15
compared to clp1-16, is able to intensify the Ts phenotype
(Figure 1C and D, row j). This additional mutation very
likely contributes to lowering the overall mutant protein
stability which results in a more drastic temperature-
sensitivity.
The genetic enhancement observed when mutations in
the ATP-binding site and the Clp1p/Pcf11p-interaction
region of the Clp1 protein are combined revealed that
these conserved regions of the central domain of the
protein are essential for Clp1p function.
mRNA 30-end formation is impaired in clp1 Ts mutant
extracts
To explore the speciﬁc function of Clp1p in pre-mRNA
30-end processing, we prepared whole cell extracts from a
wild-type strain and from the most severely affected clp1
mutants. We then performed standard in vitro pre-mRNA
cleavage and polyadenylation assays on the synthetic
CYC1 pre-mRNA as described (37). Extracts made from
the mutant strains showed a dramatic reduction of cleav-
age (Figure 2A, compare lanes 5, 8 and 10 to lanes 2, 3, 4,
6, and 9). Cleavage could be effectively restored when
puriﬁed wild-type CF IA was added to the deﬁcient ex-
tracts (Figure 2A, lane 12, 13, 14 and 18). However,
complementaton with recombinant Clp1p alone is inefﬁ-
cient to restore productive cleavage of the precursor
(Figure 2A, lanes 15–17). We next performed polyadenyla-
tion assays with the pre-cleaved CYC1 precursor
terminating at the natural poly(A) site (37). Both clp1-5
and clp1-12 mutant extracts were unable to polyadenylate
pre-cleaved CYC1 pre-mRNA (Figure 2B, compare lanes
3 and 6 to lanes 2). As observed for cleavage, addition of
CF IA efﬁciently restored polyadenylation (Figure 2B,
lane 5 and 8) in contrast to the poor improvement ob-
served when recombinant Clp1p was added (Figure 2B,
lane 4 and 7). These results conﬁrm that Clp1p, only as
part of CF IA, is directly involved in both steps of mRNA
30-end formation.
In vivo depletion of Clp1p and Pcf11p affects transcription
termination at snoRNA genes
It has been shown previously that the three components of
CF IA, Rna14p, Rna15p and Pcf11p, are required for
30-end formation of snoRNAs (42,44,45). To investigate
the importance of the last CF IA subunit in this matur-
ation process, we depleted Clp1p from cells using strains
bearing the conditional allele GAL::(Arg)-CLP1, and
used GAL::(Arg)-PCF11 as control (Figure 3A). In
such strains, the expression of Clp1p or Pcf11p can be
repressed via the strong conditional GAL10 promoter. In
addition, Clp1p and Pcf11p remaining after the switch to
glucose are efﬁciently degraded due to the presence of a
Nucleic Acids Research,2012, Vol.40, No. 3 1229destabilizing cassette consisting of a ubiquitin–arginine
moiety fused at the N-terminus of the protein of interest
(36,46). The efﬁcient depletion was conﬁrmed by western
blot analysis of extracts prepared from cells grown in
galactose only (GAL), or from cells grown in galactose
and then shifted for 4h to a glucose-containing medium
(GLU) (Figure 3B). In glucose-shifted cells, ubiquitin-
Arg-modiﬁed proteins were selectively depleted, whereas
levels of the three other CF IA subunits were not affected
(Figure 3B, lanes 2 and 4).
We next performed primer extension analysis of tran-
scripts from the SNR13-TRS31 region of the genome as
described previously (36), using the same strains as above
(Figure 3C). An oligonucleotide complementary to the
TRS31 ORF revealed extended transcripts by reverse
transcription on total RNA extracted from the
GAL::(Arg)-CLP1 and GAL::(Arg)-PCF11 strains after
a shift to glucose (Figure 3D, lanes 3 and 6, product Y)
but not from the same strains grown in galactose, or from
the wild-type strain (Figure 3D, lanes 1, 2, 4, 5, and 7, 8,
respectively; only product X is detected). For comparison,
RNA extracted from the Ts rna15-1 and pti1-2 mutants
shifted to 37 C were also tested and showed a defect in
SNR13 30-end formation, as previously demonstrated
(36,45). In this experiment, extended product Y corres-
ponds to a transcription termination defect at the 30 end
of Box C/D snoRNA SNR13, correlating with deﬁcient
snoRNA 30-end formation. Several other snoRNAs, of
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Nucleic Acids Research,2012, Vol.40, No. 3 1231both box C/D and H/ACA classes, were also affected by
depletion of Clp1p and Pcf11p (Figure 3E). As we could
observe, each tested snoRNA transcription unit was not
affected to the same extent by depletion of Clp1p and
Pcf11p. In particular, snR9 was equivalently affected by
depletion of both proteins, and equal readthrough
products accumulated with snR33 when Clp1p was either
overexpressed or depleted. We are currently unable to
explain these differences, but our results reﬂect the import-
ance of Clp1p in transcription termination at snoRNA
genes. As a result, we conclude that the whole CF IA
complex participates in 30-end formation of independently
transcribed snoRNA genes in yeast.
Ts clp1 alleles impinge on CF IA organization
To extend our analysis of the effect of CLP1 gene muta-
tions, we puriﬁed CF IA in the different mutant back-
grounds depicted in Figure 1 (see Supplementary
Table S1 for their genotypes). We generated clp1 mutant
strains in which RNA15 was TAP-tagged. Except for the
Ts strains, puriﬁed CF IA exhibited a subunit composition
similar to wild-type (Figure 4A, upper panel, compare
lanes 2, 3, 9 to lane 1). In addition, careful examination
of CF IA puriﬁed from the temperature-resistant clp1-17
mutant (G335S/L341S) showed normal levels of Rna14p
and Rna15p, but lower amounts of both Clp1p and
Pcf11p (Figure 4A, lane 7). Although only Clp1p is
mutated, the amount of Clp1p and Pcf11p displayed a
similar decrease. CF IA puriﬁed from the Ts mutant
alleles (clp1-5, -15, -16) were completely devoid of Clp1p
but more surprisingly of Pcf11p as well (Figure 4A, lanes
4–6). The relative amounts of Clp1p, Pcf11p and Rna15p
were detected by western blots from equal amounts of
puriﬁed factors probed with antibodies against these
proteins (Figure 4A, lower panel).
Multiple interactions between CF I and CPF have been
reported (10,16,21,47–49). To determine whether clp1 Ts
mutations also disrupted interactions with CPF subunits,
we puriﬁed the whole [CF IA+CPF] complex in strains
where both RNA15 and FIP1 (subunit of CPF) were
TAP-tagged. In all the clp1 Ts mutants analysed, the
band pattern of CPF proteins were similar to the wild-
type factor (Figure 4B, silver stained gel). Speciﬁcally,
the four largest subunits corresponding to the CF II
sub-complex of CPF [Cft1p/Yhh1p, Cft2p/Ydh1p,
Ysh1p/Brr5p and Pta1p; (50)] were all clearly visible, as
well as poly(A) polymerase Pap1p and Pfs2p. Although no
Clp1p could be seen in [CF IA+CPF] puriﬁed from either
clp1-5 or clp1-15, a faint band migrating at the same
size as Pcf11p in wild-type factors was discernible in the
clp1-5 mutant but not in the clp1-15 complex (Figure 4B,
lanes 3, 4). Western blot analysis with speciﬁc antibodies
conﬁrmed the presence of CF IA subunits and Pap1p
(Figure 4C). It is noticeable that the clp1-5 allele is less
affected by high temperature than the clp1-15 or clp1-12
alleles (Figure 1B and D). As a result, simultaneous puri-
ﬁcation of [CF IA+CPF] could force the cohesion of the
two factors and may explain why a residual amount of
Pcf11p was co-puriﬁed in the less affected clp1-5 allele.
However, when CF IA was puriﬁed alone from RNA15
TAP-tagged strain, Pcf11p was neither observed in clp1-5
nor in clp1-15 or clp1-16 (Figure 4A), since partitioning of
CF IA and CPF may have been forced by the puriﬁcation
procedure. Speciﬁc antibodies to Ref2p, Mpe1p and Pti1p
revealed similar amounts of these polypeptides in
[CF IA+CPF] puriﬁed from either the wild-type or
clp1-15 strains (Figure 4E).
To complement the analysis of the puriﬁed factors, we
tested their ability to cleave CYC1 and polyadenylate
CYC1 pre-cleaved precursors in assays similar to those
performed with extracts (reported in Figure 2).
Consistently, [CF IA+CPF] puriﬁed from the Ts
mutants were unable to cleave or polyadenylate the
CYC1 precursors (Supplementary Figure S2).
These results indicate that association of Clp1p and
Rna14p/Rna15p around Pcf11p is dependent upon
Clp1p and that this organization is required for the
function of CF IA in 30-end formation.
Clp1p fails to interact with Pcf11p in the clp1 Ts mutants
Puriﬁcation of CF IA in the different clp1 Ts mutants
showed that both Clp1p and Pcf11p could not associate
with Rna14p/Rna15p. However, Rna14p and Rna15p
were still able to interact with each other. We wondered
whether Pcf11p was still able to interact with the mutant
Clp1 proteins. We co-expressed the different alleles of
CLP1 in E. coli (diagrammed in Figure 1C) together
with the histidine-tagged Clp1p-binding region of Pcf11p
(amino acids 454–563) (26). Pull-down experiments
demonstrated that all of the proteins encoded by the
temperature-resistant alleles (clp1-1, -6, -13, -17, -19)
were able to interact with His6-tagged Pcf11p
(454–563).
However, none of the Ts mutant polypeptides (clp1-5,
-15, -16) co-precipitated with Pcf11p
(454–563) (Figure 5A).
Western blot analysis of total E. coli extracts expressing
the various constructs with anti-Clp1p antibodies showed
that the wild-type and mutant proteins were all expressed,
conﬁrming that the loss of interaction with Pcf11p
(454–563)
correlated with the Ts mutations and was not due to the
absence of protein expression or instability (Figure 5B).
It is interesting to observe on the western blot that the
various forms of Clp1p displayed different migration be-
haviours. Proteins encoded by clp1-13, -15,-16, -17, and
clp1-19 alleles migrated with apparent molecular weight
slightly larger than the other alleles (Figure 5B, com-
pare the Clp1 proteins on lanes 7–11 to lanes 3–6 of the
western blot). We found no direct correlation between
the migration pattern and the temperature-sensitivity of
the encoded proteins; however, a link potentially exists
with the presence of the L341S mutation, either alone
(Clp1-19p; see Figure 1C) or associated with one or two
other mutations (Clp1-15p, -13p, -16p, and -19p).
Currently, this observation has not been investigated
further but may arise from unknown protein modiﬁcation
and/or abnormal migration properties of these proteins in
SDS gels.
Finally, we tested the ability of Clp1p and its mutant
versions to interact with full-length Pcf11p with the
2-hybrid method using HIS3 as reporter gene (51,52).
To counteract some leakiness of the system, 5mM of
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Figure 4. Architecture of CF IA is destabilized by Ts mutations in the CLP1 gene. Puriﬁcation of 30-end processing complexes from wild-type and
clp1 mutant strains. (A) TAP-tagged Rna15p was used to purify CF IA from the different clp1 mutants as indicated on the top of the ﬁgure. The
different CLP1 alleles are borne on plasmids (see Supplementary Table S1). Puriﬁed complexes were run on 10% polyacrylamide–SDS gels and
stained with silver. Lower panels: equivalent amounts of factors were immunoblotted with antibodies to Pcf11p, Clp1p and Rna15p, to attest for the
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(continued)3-amino-1,2,4-triazole (3-AT) was addedto inhibitresidual
growth on media lacking histidine even in the absence of
interacting proteins. Therefore, cells carrying the empty
pACT3 vector can no longer grow at any temperature
tested in the presence of 3-AT (Supplementary Table S2,
lane pACT3). Pcf11p is fused to the Gal4p DNA-binding
domain to form the bait, and different alleles of CLP1
were merged to the activating domain of GAL4 to make
the prey. We observed that both the WT and clp1-1
temperature-resistant alleles could grow on medium
lacking histidine supplemented with 3-AT. However,
the three Ts alleles tested (clp1-5, -15 and -12) were
unable to grow at 37 C, and even at 30 C for clp1-12
(Supplementary Table S2). These results conﬁrm that the
Clp1 proteins encoded by the Ts alleles fail to interact with
wild-type full-length Pcf11p in vivo.
Recruitment of CF IA subunits to the 30-end of a protein-
coding gene in the clp1-15 mutant
Rna14p, Rna15p and Pcf11p subunits of CF IA have been
shown to associate strongly with the transcription elong-
ation complex (EC) in vivo near polyadenylation sites of
protein-coding genes (41). This association relies on the
ability of Pcf11p to directly interact with the Pol II CTD
(23). To determine whether Ts mutations in the CLP1
gene that affect CF IA assembly may also perturb their
association with the chromatin, we performed ChIP with
TAP-tagged polyadenylation factors. We ﬁrst demonst-
rated that wild-type Clp1p was able to crosslink to the
30-end region of the ADH1 gene, as the other three
CF IA subunits (Figure 6A). The predominant ampliﬁca-
tion of PCR fragment number 3 illustrated this preferred
localization (Figure 6B and C). The enhanced occupancy
of Clp1p observed when cells were shifted from 24 Ct o
37 C most likely reﬂects the average increase of transcrip-
tion rates observable after a 1h shift to 37 C, as reported
previously (53). We then tested the ability of the mutant
Clp1-15 protein to crosslink near the polyadenylation site.
If Clp1-15p could still crosslink at the permissive tempera-
ture as efﬁciently as the wild-type protein, we observed
that the signal is lost after shift to the non-permissive tem-
perature (Figure 6B, right panels).
We next examined cross-linking of Pcf11p and Rna15p
to the ADH1 gene. In the wild-type CLP1 strain, Pcf11p
and Rna15p cross-linked strongly to the 30 region of the
ADH1 gene at both 24 Ca n d3 7  C (Figure 6D and F,
respectively). In the clp1-15 mutant background, cross-
linking of Pcf11p was moderately affected at 37 C in com-
parison to the crosslink measured at 24 C (Figure 6D and
E). On the other hand, the Rna15p crosslink dropped by
half in comparison to that observed at the permissive tem-
perature (Figure 6F-G). This difference can be explain by
the fact that Pcf11p bears an independent domain that spe-
ciﬁcally interacts with the CTD of RNA polymerase II (23).
Hence, it may be less sensitive to mutations in the CLP1
gene that Rna15p in the ChIP assay.
It has been shown recently that Rna14p and Rna15p are
tightly associated with each other via their monkeytail and
hinge domains, respectively, to such an extent that only
mutations within one of these regions disrupt their asso-
ciation (19). As Rna14p still binds to Rna15p in the
puriﬁed factor (Figure 4), we anticipate from the loss of
Rna15p cross-link in the clp1-15 mutant that association
of Rna14p with the chromatin may also drop to the same
extent. In a similar situation, rna14-1 mutation abolished
Rna15p cross-linking at the 30-end of genes (41).
Figure 4. Continued
presence of the subunit. M, molecular weight makers, sizes in kDa are indicated on the left. (B) Co-puriﬁcation of [CF IA+CPF] from wild-type and
clp1 Ts mutant strains where both Rna15p and Fip1p where TAP-tagged (the tagged subunit is marked with a asterisk). WT, wild-type factors
prepared from YSD13 [lane 1; (38); CLP1 (lane 2), clp1-5 (lane 3), clp1-15 (lane 4)]: factors prepared from strains where the different CLP1 alleles
are carried on a plasmid (see Supplementary Table S1). Protein complexes were run on 10% polyacrylamide–SDS gels and stained with silver, as in
(B). Arrows point to the Pcf11 and Clp1 proteins. M, molecular weight makers, in kiloDaltons. (C) Puriﬁed [CF IA+CPF] shown in (B) were
analysed by immunoblotting with antibodies to Rna14p, Pcf11p, Pap1p, Clp1p, and Rna15p to check for their presence. Equal amounts of
[CF IA+CPF] puriﬁed from wild-type (YRH73) and mutant clp1-15 (YRH69) strains were run on 10% polyacrylamide–SDS gels and either
stained with silver (D), or (E) immunoblotted with antibodies against Clp1p (blot 1), Mpe1p and Clp1p (blot 2), Mpe1p and Pti1p (blot 3)
and Ref2p and Clp1p (blot 4). In vitro 30-end processing assays were also performed with the puriﬁed [CF IA+CPF] factors (see Supplementary
Figure S2).
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Figure 5. Pcf11p can no longer interact with Ts forms of Clp1p.
Pull-down experiments with His6-Pcf11p
(454–563) and the different alleles
of Clp1p co-expressed in E. coli.( A) The proteins were co-expressed in
BL21(DE3) cells and pulled down with a cobalt-afﬁnity resin. The
bound proteins were released by boiling in loading buffer, run on a
15% polyacrylamide–SDS gel and stained with Coomassie. Lane 1,
expression of His6-Pcf11p
(454–563) alone in bacteria; lane 2, control with
expression vector alone; lanes 3-11, co-expression of His6-Pcf11p
(454–563)
with all the different forms of Clp1p, as diagrammed in Figure 1A
and C. M, molecular weight makers, in kiloDaltons. (B) Aliquots of
supernatants from the pull-down assays were loaded on a 10% poly-
acrylamide–SDS gel and immuno-blotted with antibodies to Clp1p to
attest for the expression of the different versions of the protein.
Loading was done in the same order as in (A). Interaction between
Clp1 mutant proteins and full-length Pcf11p were also tested with the
2-hybrid system in vivo (see Supplementary Table S2).
1234 Nucleic Acids Research, 2012,Vol.40, No. 3Therefore, cross-linking of CF IA subunits to the 30-end
of genes is sensitive to mutations in the CLP1 gene. The
less efﬁcient recruitment of Rna15p in clp1-15 mutant and
the overall destabilization of CF IA complex very likely
inﬂuences negatively the efﬁciency of the coupling between
transcription termination and 30-end formation.
Altogether, the results presented in this article strongly
suggest that Clp1p is required to maintain the assembly of
a functional CF IA in order to ensure its function in
pre-mRNA 30-end processing and transcription
termination.
DISCUSSION
In this study, we have investigated the function of the
yeast Clp1 protein, one of the four subunits of CF IA,
Figure 6. Cross-linking of CF IA subunits at the 30-end of the ADH1 gene. Strains carrying TAP-tagged Clp1p, Clp1-15p, Pcf11p, or Rna15p were
analysed by ChIP of the ADH1 gene. (A) Schematic representation of the ADH1-YOL087C locus on the chromosome. Broken arrows represent the
transcription start sites, the open arrowhead shows the polyadenylation site. The four fragments ampliﬁed by PCR and used in the ChIP analysis are
represented as bars below the gene and numbered. (B) ChIP analysis with TAP-tagged Clp1p-and TAP-tagged Clp1-15p-expressing strains cultivated
at the permissive temperature (24 C) or shifted to 37 C for 1h. PCR-ampliﬁed fragments of IP chromatin were analysed by electrophoresis on 8%
non-denaturing polyacrylamide gels. IP, chromatin IP by TAP-tagged Clp1p and subjected to PCR with primer pairs amplifying fragments 1–4 as
depicted in (A); Input, total input chromatin. Asterisk: background control from a non-transcribed region of chromosome V. (C) Clp1p and
Clp1-15p occupancy values quantitated as described in ‘Materials and Methods’ section. The TAP-tagged Clp1p and Clp1-15p-expressing strains
(YLM204 and YLM215, respectively) were grown at 24 C or shifted to 37 C for 1h. For easier comparison, the highest value obtained with
fragment number 3 for each immunoprecipitation was set up to 100 and other values were expressed relative to this maximum. Values represent the
average of three independent experiments, and error bars indicate average deviations. (D and E) ChIP analysis with TAP-tagged Pcf11p in CLP1
(WT; YLM198) and clp1-15 (YLM201) strains cultivated at the permissive temperature (24 C) or shifted to 37 C for 1h. Quantitation of results were
carried out as in (C). (F and G) ChIP analysis on ADH1 and quantitation of the results obtained with TAP-tagged Rna15p in CLP1 (WT; YLM184)
and clp1-15 (YLM206) strains cultivated at 24 C and shifted to 37 Ca si n(D and E). Values in (D and E) and (F and G) represent the average of
three independent experiments, and error bars indicate average deviations.
Nucleic Acids Research,2012, Vol.40, No. 3 1235factor involved in polyadenylation. We have isolated Ts
mutants of the CLP1 gene that abolish pre-mRNA 30-end
cleavage and polyadenylation and showed that in vivo
depletion of Clp1p and Pcf11p inhibit termination of
transcription at Pol II-transcribed snoRNA genes.
Therefore, altered expression of all four subunits of
CF IA abolish 30 processing and transcription termination
(1,20,23,24,37,42), underscoring the essential role of this
factor in the coupling of polyadenylation and Pol II ter-
mination. Clp1 also exists in humans and exhibits an
RNA-kinase activity in tRNA splicing, as a component
of the tRNA splicing endonuclease complex, and in
siRNA activation (28). Associated with hPcf11 in
CF IIm, hClp1 is required for cleavage of the pre-
mRNA transcript (25). However, its role as a kinase in
pre-mRNA 30-end processing has not been documented.
The enzymatic activity of Clp1 was predicted by the pres-
ence of a P-loop/Walker A motif in its primary sequence,
reinforced by the crystal structure of the yeast protein
(26). Despite these particular features, no kinase activity
has yet been ascribed to yeast Clp1p (26,27).
The mutations found to inhibit processing are located
within the ATP-binding domain and the Clp1p–Pcf11p
interacting region. The most striking feature of these
mutations is that they have to be combined to cause
temperature-sensitivity. Remarkably, this phenotype is
always linked with dissociation of the tetrameric architec-
ture of CF IA, leaving Rna14p/Rna15p together on one
side whereas Pcf11p and Clp1p fall apart individually.
Alternatively, combination of two mutations at the
Clp1p-Pcf11p interface (G335S/L341S) did not result in
the loss of interaction between both of them, nor result
in a conditional lethal phenotype. Therefore, it seems
likely that CF IA remains assembled and functional as
long as Pcf11p can interact with Clp1p. Since Pcf11p is
the only component of CF IA to interact with all of
the other subunits, Clp1p may send a ‘signal’ through
Pcf11p to allow the association of Rna14p/Rna15p. We
propose that the interaction between Clp1p and Pcf11p
involves conformational rearrangements of both pro-
teins such that Rna14p/Rna15p associate with CF IA.
Additionally, these conformational changes must rely on
an intact ATP binding site. The G135R mutation we
found in the P-loop domain has no phenotypic effect on
yeast. Other mutants have been described in which the
neighbouring amino acids K136-T137 were changed into
alanine. These mutants are also viable with no detectable
phenotype at 37 C (27). Yet, equivalent mutations in the
P-loop domain of either hClp1 or the T4 polynucleotide
kinase abolish their activity (27,28). We postulate that the
G135R mutation in yeast Clp1p has no detectable effect
on growth because it affects only moderately the conform-
ational rearrangement of the protein, such that Pcf11p can
still interact efﬁciently with Clp1p and thus recruit
Rna14p/Rna15p. However, additional mutations, such
as G335S or L341S, in the distant Clp1p–Pcf11p binding
region (Supplementary Figure S1B), may modify the struc-
ture of Clp1p to such an extent that it can no longer
interact with Pcf11p and induce the conformational
change to Pcf11p required to recruit Rna14p/Rna15p. In
the double mutant clp1-17 (G335S/L341S), a decrease in
the amount of both Clp1p and Pcf11p associated with
puriﬁed CF IA does not result in a lethal phenotype.
This reinforces the concept that the ATP-binding
domain has an essential function, as mutations in it have
a synergistic lethal effect at 37 C when combined with
single mutations at the Clp1p-Pcf11p interface. Our data
are showing that Pcf11p–Clp1p interaction is essential.
Whether or not they can act in vivo as a dimer, as in
mammals within CF IIm, adjacent to a dimeric Rna14p/
Rna15p sub-complex, remains unknown but our mutants
might cast light on the separation of mammalian CF IIm
and CstF (comprising Rna14p/Rna15p counterparts) in
evolution.
The potential change in the Clp1p ATP-binding pocket
due to the G135R mutant can be predicted from the
available crystal structure of Clp1p-Pcf11p
(454-563) (26).
In the wild-type protein, the G135 backbone amide
provides hydrogen-bonding to the b-phosphate group of
the ATP. This interaction is further stabilized by the adja-
cent amino acids T134, K136 and T137. The a- and
g-phosphates are also bound by residues of the Clp1p
base-binding loop. The G135R mutation would be pre-
dicted to provoke perturbation of this extensive binding
network due to the signiﬁcantly larger side-chain of argin-
ine compared to glycine (Figure 7). It is most likely that
the arginine side chain interferes with the ATP binding
and also its orientation in its binding pocket, although
K136 K136
T134 T134
G135 R135
B G135
D311
V313 S314
Q133
V315
K136
S132
T134 K309
L310
A
Figure 7. The Clp1p ATP-binding site. (A) Close view of the ATP-binding pocket of Clp1p, according to Noble et al. (26). Residues of the Switch I
and II loops are shown in purple. The G135 position is coloured in red. The Mg
2+ ion is coloured in green. (B) Cartoon representation of the G135R
mutation and the neighbouring amino acids, emphasizing the side chain difference between the two amino acids.
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either case, the change of the ATP-binding region never-
theless remains non-lethal until an additional mutation is
introduced in the quite remote Pcf11p-interaction domain.
The combined effect effectively prevents, accentuates or
otherwise alters the normal transduction of the conform-
ational change such that the lethal phenotype results.
In addition to the effect of the clp1 Ts mutations on the
assembly of the puriﬁed factor, we have also investigated
the consequence on the recruitment of CF IA subunits to
the elongating Pol II on the chromatin. We have found
that these mutations decrease slightly but signiﬁcantly the
cross-linking of Pcf11p to the ADH1 polyadenylation site
while they more severely affect Rna15p recruitment. The
loss of Rna15p cross-linking is consistent with its separ-
ation from the puriﬁed factor together with Rna14p to
which it interacts tightly, by way of their hinge and
monkeytail domains, respectively (19). If we consider
Pcf11p as the scaffolding subunit of CF IA around
which Clp1p, Rna14p/Rna15p organize, we can envisage
that recruitment of Rna14p/Rna15p to the chromatin pre-
viously reported (41) may only occur if Clp1p interacts
productively with Pcf11p. The ﬁnding that Pcf11p is still
able to partially crosslink near the poly(A) site in clp1
mutants may likely be due to the fact that Clp1p,
Rna14p, and Rna15p-interacting regions of the protein
are not overlapping with its CID (23). Therefore, the as-
sumption that mutant Clp1 proteins can no longer induce
conformational changes through Pcf11p does not neces-
sarily imply that it impinges on the direct interaction
between Pcf11p and Pol II CTD.
It is well established that termination of transcription by
RNA polymerase II is dependent upon both the 30-end
processing signals and the cleavage/polyadenylation
factors (1,23,24,41,54). In clp1 mutants, Pcf11p is still
recruited to the 30-end of genes and does not crosslink
beyond the site of termination since fragment 4 does not
co-immunoprecipitate with Pcf11p (Figure 6). It has been
shown by Gilmour and colleagues (55) that the CID of
yeast Pcf11p is able to dismantle in vitro Pol II ECs, thus
triggering transcription termination. Their conclusions
have been extended to dPcf11 in Drosophila (56). They
propose that CF IA ﬁrst recognizes the positioning
element of the polyadenylation signal after synthesis,
allowing subsequent Pcf11p recruitment to Pol II CTD.
In this conﬁguration, Pcf11p can bridge both the CTD
and the transcript, creating forces that are transmitted to
the EC, resulting in the dissolution of the complex and
termination (55). Conformational changes are invoked
to induce CTD rearrangements so that the RNA can no
longer interact with Pcf11p CID.
We believe our results are compatible with this model
and extend it further. We observed that Clp1p binding to
Pcf11p is required to allow formation of a stable tetramer-
ic factor. In the normal situation in vivo, CF IA binds to
the nascent transcript emerging from the elongating poly-
merase, permitting the interaction of Pcf11p with
Pol II-CTD. We postulate that the conformational
changes of the CTD proposed by Zhang et al. (55) and
required to dismantle Pol II EC would be transmitted
through Pcf11p by Clp1p in vivo. This mechanism would
maintain the obligatory association of CF IA-bound
primary transcript and the EC to allow efﬁcient dismantl-
ing. This cascade of conformational changes, transmitted
to the CTD and the nascent transcript, could involve
ATP hydrolysis by the putative kinase activity of Clp1p,
only in the context of the whole machinery. This enzym-
atic activity is not observable in vitro with recombinant
Clp1p (26) or even with Clp1p embedded in CF IA
(L.M.-S., unpublished observation). In this model, con-
formational changes after ATP hydrolysis would be trig-
gered by the interaction of Clp1p/CF IA with other
components of the processing complex. Clp1p is structur-
ally related to members of the SIMIBI class of ATPases
(26,57), such as the Azobacter vinelandii NifH nitrogenase
and the E. coli detoxiﬁcation pump protein ArsA. These
proteins are subunits of macromolecular complexes and
nucleotide hydrolysis is activated only upon their inter-
action with members of the complex. Interestingly, ATP
hydrolysis is required to induce conformational rearrange-
ments (58,59). These data on related proteins of the same
family with ATPase activity support our model that Clp1p
may have kinase activity required during 30-end
processing-coupled transcription termination.
The fact that Pcf11p is capable of dismantling the EC as
reported by Zhang et al. (55) without the help of Clp1p or
any additional external activity might be due to the fact
that these experiments were carried out in vitro in a
simpliﬁed system where isolated ECs and Pcf11p CID
were used. In this situation, it may be that the CID is
constitutively active with regard to termination by
dismantling of the Pol II EC.
In the clp1 Ts mutant situation, CF IA disassembles
after the shift to the non-permissive temperature and
cleavage of the primary transcript is abolished. Pcf11p
can still interact with Pol II CTD via its independent
CID but Clp1p-induced conformational changes can no
longer be transmitted through components of the
polyadenylation machinery and termination does not
occur.
In agreement with our results, C. Moore and coworkers
(Ghazy et al., accepted for publication) found that dras-
tic amino acid changes in the ATP-binding site, K136E
and T137W, are lethal. They propose that these mutations
modify the orientation of the ATP molecule within its
pocket to such a point that it blocks Clp1p in a
non-reversible conformation. Consistently, the mutant
proteins can no longer interact with Pcf11p. They
also show that mutations in Pcf11p that disrupt Clp1/
Pcf11p interaction have the same dramatic effects on
30 processing and transcription termination that we
found in our study.
Further experiments will be required to test the validity
of this model. For instance, it would be important to show
that CF IA is indeed capable in vitro of dismantling the
elongating polymerase complex as does Pcf11p CID alone.
In the case of a mutant Clp1p that does not provoke dis-
sociation of the factor but affects its putative catalytic
activity, one might also see that EC dismantling is
affected. This in vitro system could possibly reveal the
yet mysterious kinase activity of yeast Clp1p.
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